Read More Apparatus Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Nov 06, 2024
Read More Apparatus "New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial Nov 10, 2024
Read More Apparatus Genkore Announces Collaboration With Us Company On In Vivo Gene Editing Therapies Nov 16, 2024
